COVID-19 Pandemic Disrupts Cardiovascular Services Worldwide
Cardiac services worldwide experience severe disruptions during the COVID-19 pandemic, compromising access to essential cardiovascular care and highlighting the need for resilient healthcare systems to mitigate collateral damage.
Februery 2023
Retinal Examination Holds Predictive Value for Assessing Heart Attack Risk
Development of a predictive model using retinal examination data enables accurate assessment of the risk of acute myocardial infarction (AMI), providing a non-invasive tool for identifying individuals at heightened cardiovascular risk.
Februery 2023
Prediabetes Increases Risk of Type 1 Myocardial Infarction and Hospitalization
Individuals with prediabetes are at higher risk of type 1 myocardial infarction and hospitalization for heart attacks compared to those without prediabetes, emphasizing the importance of early intervention and cardiovascular risk management in this population.
Februery 2023
Percutaneous Implantation Versus Surgical Aortic Valve Replacement: One-Year Follow-Up Results from a Randomized Clinical Trial
The DECAAF II trial provides one-year follow-up results comparing percutaneous implantation and surgical aortic valve replacement, offering insights into the safety and efficacy of these interventions for aortic valve disease management.
Februery 2023
Arterial Stiffness Predicts Type 2 Diabetes Risk Better Than Hypertension
Arterial stiffness shows better predictive capacity for type 2 diabetes risk than hypertension alone, underscoring the potential utility of arterial stiffness measurements in identifying individuals at higher risk of developing diabetes.
Februery 2023
USPSTF Recommends Against Aspirin for Primary Cardiovascular Prevention in Older Adults
The US Preventive Services Task Force (USPSTF) recommends against initiating low-dose aspirin for primary prevention of cardiovascular disease in adults aged 60 years and older, citing insufficient evidence of net benefit and potential harms.
Februery 2023
Rome IV Criteria Provide Superior Classification of Heartburn Conditions
The Rome IV criteria demonstrate superior diagnostic accuracy for distinguishing between non-erosive esophageal disease, functional reflux, and reflux hyperreactivity, facilitating more precise classification and management of heartburn-related conditions.
January 2023
